Factors modifying stress from adverse effects of immunosuppressive medication in kidney transplant recipients

Clinical Transplantation

Volumn 19, Issue 1, 2005, Pages 70-76

  Rosenberger, Jaroslav ^a   Geckova, Andrea Madarasova ^b   van Dijk, Jitse P ^c   Roland, Robert ^a   van den Heuvel, Wim J A ^d   Groothoff, Johan W ^c  

^a L PASTEUR UNIVERSITY HOSPITAL   (Slovakia)

^b P J AFÁRIK UNIVERSITY   (Slovakia)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Adverse effects; Immunosuppression; Kidney transplantation; Quality of life; Stress

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; AGE; AGED; ANALYSIS OF VARIANCE; ANXIETY; ARTICLE; BODY WEIGHT DISORDER; CONTROLLED STUDY; DEPRESSION; DIARRHEA; EDUCATION; FACE DISORDER; FACE EDEMA; FEAR; FEMALE; GINGIVA HYPERPLASIA; GRAFT FAILURE; HAIR LOSS; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERVIEW; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LEG EDEMA; MAJOR CLINICAL STUDY; MALAISE; MALE; MEDICAL RECORD; MUSCLE WEAKNESS; PAIN; PATIENT COMPLIANCE; PERITONEAL DIALYSIS; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; QUALITY OF LIFE; SEX DIFFERENCE; SEXUAL DYSFUNCTION; SIDE EFFECT; SKIN DEFECT; SLEEP DISORDER; SLOVAKIA; SOCIAL SUPPORT; STRESS; WEIGHT GAIN;

ADOLESCENT; ADULT; AGED; ANXIETY; DEPRESSION; EDUCATIONAL STATUS; FACIES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MUSCLE WEAKNESS; PAIN; SEX FACTORS; STRESS, PSYCHOLOGICAL; WEIGHT GAIN;

EID: 13644264364     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2004.00300.x     Document Type: Article

References (31)

1. Hayward MB, Kish JP, Frey GM, Kirchner JM, Carr LS, Wolfe CM. An instrument to identify stressors in renal transplant recipients. ANNA J 1989: 16: 81.
2. Frey GM. Stressors in renal transplant recipients at six weeks after transplant. ANNA J 1990: 17: 443, 450.
3. White MJ, Ketefian S, Starr AJ, Voepel-Lewis T. Stress, coping, and quality of life in adult kidney transplant recipients. ANNA J 1990: 17: 421, 431.
4. El Agroudy AE, Bakr MA, El Dein ABS, Ghoneim MA. Death with functioning graft in living donor kidney transplantation: analysis of risk factors. Am J Nephrol 2003: 23: 186.
5. Ducloux D, Motte G, Billerey C et al. Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2-year follow-up. Transplant Int 2002: 15: 387.
6. Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transplant 1998: 12: 147.
7. Newstead CG. Assessment of risk of cancer after renal transplantation. Lancet 1998: 351: 610.
8. Hetzer R, Albert W, Hummel M et al. Status of patients presently living 9 to 13 years after orthotopic heart transplantation. Ann Thorac Surg 1997: 64: 1661.
9. Aker S, Ivens K, Guon Z, Brabensee B, Heering P. Cardiovascular complications after renal transplantation. Transplant Proc 1998: 30: 2039.
10. Laupacis A, Pus N, Muirhead N, Wong C, Ferguson B, Keown P. Disease-specific questionnaire for patients with a renal transplant. Nephron 1993: 64: 226.
11. Fallon M, Gould D, Wainwright SP. Stress and quality of life in the renal transplant patient: a preliminary investigation. J Adv Nurs 1997: 25: 562.
12. Hricik DE, Halbert RJ, Barr ML et al. Life satisfaction in renal transplant recipients: preliminary results from the transplant learning center. AJKD 2001: 38: 580.
13. Matas AJ, Halbert RJ, Barr M L et al. Life satisfaction and adverse effects in renal transplant recipients: a longitudinal analysis. Clin Transplant 2002: 16: 113.
14. Jindal RM, Baines LS. Noncompliance after solid organ transplantation. Transplantation 2001: 72: 1583.
15. Hathaway DK, Combs C, De Geest S, Stergachis A, Moore LW. Patient compliance in transplantation: a report on the perceptions of transplant clinicians. Transplant Proc 1999: 31(Suppl. 4A): 10S.
16. Baines LS, Joseph JT, Jindal RM. Compliance and late acute rejection after kidney transplantation: a psychomedical perspective. Clin Transplant 2002: 16: 69.
17. de Geest S, Borgermans L, Gemoets H et al. Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplantation 1995: 59: 340.
18. De Geest S, Abraham I, Dunbar-Jacob J. Measuring transplant patients' compliance with immunosuppressive therapy. West J Nurs Res 1996: 18: 595.
19. Moons P, De Geest S, Abraham I, van Cleemput J, Vanhaecke J. Symptom experience associated with maintenance immunosuppression after heart transplantation: patients' appraisal of side effects. Heart Lung 1998: 27: 315.
20. Lough ME, Lindsey AM, Shinn JA, Stotts NA. Impact of symptom frequency and symptom distress on self-reported quality of life in heart transplant recipients. Heart Lung 1987: 16: 193.
21. Valderrábano F, Jofre R, López-Gómez JM. Quality of life in end-stage renal disease patients. AJKD 2001: 38: 443.
22. Moons P, Fairchild S, de Geest S. Patients' appraisal of side effects in quality of life assessments of immunosuppressive regimens. In: Cochat P, Traeger J, Merieux C, Derchavane M, eds. Immunosuppression under Trial. Dordrecht: Kluwer Academic Publishers, 1999: 69.
23. de Geest S, Moons P. The patient's appraisal of side-effects: the blind spot in quality-of-life assessments in transplant recipients. Nephrol Dial Transplant 2000: 15: 457.
24. Hasselder A. Renal transplant: long-term effects of immunosuppression. Prof Nurse 1999: 14: 771.
25. Jensen S, Jackson EC, Riley L, Reddy S, Goebel J. Tacrolimus-based immunosuppression with steroid withdrawal in pediatric kidney transplantation - 4-year experience at a moderate-volume center. Pediatr Transplant 2003: 7: 119.
26. Sutton TD, Murphy SP. Stressors and patterns of coping in renal transplant patients. Nurs Res 1989: 38: 46.
27. Breza J, Reznicek J, Pribylincova V, Zvara P. Erectile dysfunctions in patients treated with hemodialysis and kidney transplantation. Bratisl Lek Listy 1993: 94: 489.
28. Keown P. Improving quality of life - the new target for transplantation. Transplantation 2001: 72(Suppl.): SS67.
29. Reimer J, Franke GH, Philipp T, Heemann U. Quality of life in kidney recipients: comparison of tacrolimus and cyclosporine-microemulsion. Clin Transplant 2002: 16: 48.
30. Reimer J, Franke GH, Kohnle M, Philipp T, Heemann U. Quality of life after kidney transplantation - the impact of tacrolimus. Transplant Proc 2001: 33: 1924.
31. Shield CF III, McGrath MM, Goss TF. Assessment of health-related quality of life in kidney transplant patients receiving tacrolimus (FK506)-based versus cyclosporine-based immunosuppression. Transplantation 1997: 64: 1738.